Library Services | Technical University of Kenya

Your cart is empty.
Normal view MARC view ISBD view

Twenty Years of G-CSF [electronic resource] : Clinical and Nonclinical Discoveries / edited by Graham Molineux, MaryAnn Foote, Tara Arvedson.

By: Molineux, Graham [editor.].
Contributor(s): Foote, MaryAnn [editor.] | Arvedson, Tara [editor.] | SpringerLink (Online service).
Material type: materialTypeLabelBookSeries: Milestones in Drug Therapy: Publisher: Basel : Springer Basel, 2012Description: XXII, 471p. 54 illus., 4 illus. in color. online resource.Content type: text Media type: computer Carrier type: online resourceISBN: 9783034802185.Subject(s): Medicine | Oncology | Immunology | Toxicology | Hematology | Cytokines | Biomedicine | Pharmacology/Toxicology | Cancer Research | Immunology | Cytokines and Growth Factors | HematologyDDC classification: 615 Online resources: Click here to access online
Contents:
Basic Science -- Use of rHuG-CSF in the Oncology Setting -- Use of rHuG-CSF in Non-Oncology Setting -- Safety and Economics -- The Next 20 Years.
In: Springer eBooksSummary: Granulocyte colony-stimulating factor (G-CSF or GCSF) is a secreted glycoprotein that stimulates the proliferation and differentiation of granulocyte precursor cells, and induces mobilization of peripheral blood progenitor cells from the bone marrow. Development of recombinant human G-CSF has had a profound impact on the treatment of many diseases, including severe chronic neutropenia and cancer, and has enabled peripheral stem cell transplantation to supplant bone marrow transplantation in the autologous setting. This Milestones in Drug Therapy volume describes the experience of the last 20 years of treatment with recombinant human G-CSF, including the basic science, the use of recombinant human G-CSF in both the oncology and nononcology settings, and the safety and economics of its use. Many of the authors were the original investigators of recombinant human G-CSF and other authors are key researchers who provide their outlook for the next 20 years for use of and research with recombinant human G-CSF.
Tags from this library: No tags from this library for this title. Log in to add tags.
No physical items for this record

Basic Science -- Use of rHuG-CSF in the Oncology Setting -- Use of rHuG-CSF in Non-Oncology Setting -- Safety and Economics -- The Next 20 Years.

Granulocyte colony-stimulating factor (G-CSF or GCSF) is a secreted glycoprotein that stimulates the proliferation and differentiation of granulocyte precursor cells, and induces mobilization of peripheral blood progenitor cells from the bone marrow. Development of recombinant human G-CSF has had a profound impact on the treatment of many diseases, including severe chronic neutropenia and cancer, and has enabled peripheral stem cell transplantation to supplant bone marrow transplantation in the autologous setting. This Milestones in Drug Therapy volume describes the experience of the last 20 years of treatment with recombinant human G-CSF, including the basic science, the use of recombinant human G-CSF in both the oncology and nononcology settings, and the safety and economics of its use. Many of the authors were the original investigators of recombinant human G-CSF and other authors are key researchers who provide their outlook for the next 20 years for use of and research with recombinant human G-CSF.

There are no comments for this item.

Log in to your account to post a comment.

2017 | The Technical University of Kenya Library | +254(020) 2219929, 3341639, 3343672 | library@tukenya.ac.ke | Haile Selassie Avenue